Non-specific CPT/HCPCS codes — provider actions

Use non-specific or unlisted CPT/HCPCS codes (eg, 45399, 81479, 81599, 84311, 86486, 87449, 87450, 88749, 89398, 93998, 96379) only when there is no specific code that accurately describes the service or item provided. Non-specific codes commonly trigger additional documentation requests and prior authorization or may be denied if documentation does not clearly justify why a specific code could not be used. Providers should attach operative reports, test methodology, drug/biologic product information, and manufacturer/model numbers as applicable when billing these codes.

• Attach clinical documentation describing the service and why no specific code applies
• Include operative notes, laboratory method details, organism tested, or test platform when relevant
• Expect prior authorization or medical record review for unlisted procedure or laboratory codes

Additional non-specific HCPCS codes — billing cautions

Additional non-specific HCPCS examples (A0999, A9280, A9597, A9598, A9699, A9900, A9999, B9998, B9999, C1889, E1399, E1699, E2399, E2599, G0247) often represent supplies, DME components, ambulance or procedure adjuncts. When billing these codes, providers must document the item’s function, relation to the primary service, and, for DME/supplies, supplier details and invoice/receipt information. Unspecified HCPCS codes may be reviewed for bundling or more appropriate specific HCPCS/CPT codes.

• Provide supplier invoices, device model/serial numbers, and clinical justification for use of miscellaneous HCPCS codes
• Verify whether a specific HCPCS or CPT code exists before using a miscellaneous code to avoid denials or edits
• Be aware of possible bundling edits when submitting miscellaneous supply or DME components

Unclassified drug/biologic codes — provider actions

Unclassified drug and biologic codes (for example J1040, J1050, J3490, J3590, J7198, J7199, J7505, J9999) require clear documentation of the exact product administered: drug name, strength, NDC when available, dose, route, and supporting medical necessity. These J‑code entries commonly prompt drug-specific prior authorization, and J3490/J3590 often require attachment of manufacturer labeling or compendia support.

• Include NDC, manufacturer, vial size, quantity dispensed, and administration details when billing unclassified drug/biologic codes
• Confirm whether a specific J‑code exists for the product; use unlisted J‑codes only when no specific code applies
• Expect prior authorization or clinical review for high-cost or off‑label biologic/drug therapies

Prosthetics/orthotics/supplies unlisted codes — billing cautions

Unlisted prosthetics/orthotics/supplies codes (examples: K0108, K0462, K0547, L1499, L3649, L3999, L5999, L7499, L8499, L8699, L9900, Q4082, Q4100, S5001, S9542, T1999, T5999, V5299) require detailed product descriptions, device measurements, fitting notes, supplier invoices, and clinical justification. These codes are frequently subject to clinical review and may be denied if a more specific L-, Q-, K-, S-, or T-code applies or if documentation is inadequate.

• Attach supplier invoice, product description, model numbers, fitting notes, and reason a specific prosthetic/orthotic code was not used
• Verify coverage and prior authorization requirements for custom or replacement prosthetic/orthotic items
• Document repairs or temporary replacements separately (eg, K0462) and include member‑owned equipment details when applicable